Avidity Biosciences, Inc. (RNA)
Avidity Biosciences Market Cap: 10.74B for Dec. 9, 2025
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Novartis AG | 251.38B |
| Eli Lilly & Co. | 879.11B |
| Dyne Therapeutics, Inc. | 2.634B |
| Astria Therapeutics, Inc. | 739.25M |
| Intellia Therapeutics, Inc. | 1.077B |
Market Cap Related Metrics
| PS Ratio | 448.65 |
| PEG Ratio | -0.3895 |
| Price to Book Value | 5.696 |
| Price | 71.30 |
| Earnings Yield | -5.85% |
| PEGY Ratio | -0.3895 |